(Q45076912)

9 December 2017

title

Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5-fluorouracil and mitomycin-C. (English)

1 reference

advanced head and neck cancer

9 December 2017

0 references

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

Hans Christiansen

1

1 reference

9 December 2017

Robert M Hermann

2

1 reference

9 December 2017

Andrea Hille

3

1 reference

9 December 2017

Elisabeth Weiss

4

1 reference

9 December 2017

Mirko Nitsche

5

1 reference

9 December 2017

Alexios Martin

6

1 reference

9 December 2017

Clemens F Hess

7

1 reference

9 December 2017

Olivier Pradier

8

1 reference

9 December 2017

publication date

1 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

26

1 reference

9 December 2017

issue

10

1 reference

9 December 2017

page(s)

845-853

1 reference

Radiotherapy combined with simultaneous chemotherapy with mitomycin-C and 5-fluorouracil for inoperable head and neck cancer

9 December 2017

cites work

1 reference

A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma

21 January 2018

1 reference

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials

21 January 2018

1 reference

7 January 2021

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

1 reference

7 January 2021

Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy

1 reference

7 January 2021

Tissue oxygen distribution in head and neck cancer patients

1 reference

7 January 2021

Mitomycin C in combination with radiotherapy as a potent inhibitor of tumour cell repopulation in a human squamous cell carcinoma

1 reference

7 January 2021

EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system

1 reference

7 January 2021

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

1 reference

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

7 January 2021

Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study

1 reference

7 January 2021

Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx

1 reference

7 January 2021

Pre-treatment anaemia alters outcome in early squamous cell carcinoma of the larynx treated by radical radiotherapy

1 reference

7 January 2021

Clinical radiobiology of glottic T1 squamous cell carcinoma

1 reference

7 January 2021

Influence of the hypoxic subvolume on the survival of patients with head and neck cancer

1 reference

7 January 2021

[Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas]

1 reference

7 January 2021

The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

7 January 2021

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

1 reference

7 January 2021

Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer

1 reference

7 January 2021

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience

1 reference

7 January 2021

Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma

1 reference

7 January 2021

Synchronous 5-fluorouracil, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix

1 reference

7 January 2021

Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy

1 reference

7 January 2021

Chemo-radiotherapy for locally advanced head and neck cancer--long-term results of a phase II trial

1 reference

7 January 2021

Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.

1 reference

7 January 2021

Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer--preliminary report

1 reference

7 January 2021

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

7 January 2021

Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1 reference

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

7 January 2021

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers

1 reference

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.20030

1 reference

release_4h4edcms6vd7pht56qad5lppdq

9 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4h4edcms6vd7pht56qad5lppdq

24 November 2022

mapped directly with Wikidata item

1 reference